Latest
By Staff Report / Monday, October 25th, 2010 / Latest news, Technology / Comments Off on FDA OKs Aranesp for pre-dialysis patients
Amgen’s anemia treatment Aranesp is safe for kidney patients whose disease doesn’t require dialysis, a federal panel announced Oct. 18 in response to a study that found the drug could increase stroke risk in those patients. Outside advisers to the U.S. Food and Drug Administration said the treatment shouldn’t be withdrawn or limited to a Read More →
Latest
By Stephen Nellis / Monday, October 4th, 2010 / Top Stories / Comments Off on CytomX to take venture money and run
Santa Barbara-based biotech firm CytomX Therapeutics has raised $30 million in venture capital and announced plans to move to the San Francisco Bay Area by the end of the year. The company is developing technology that would help antibodies better target the disease tissue they’re intended for, reducing harmful side effects. It was founded by Read More →
